Dr. Tom Elliott, Author at BCDiabetes

CREDENCE – more evidence of benefits with SGLT2 inhibitors – write to your MLA

Research

Today (2019-Apr-15) the results of the much anticipated CREDENCE study which examined the benefits of canagliflozin (a member of the SGLT2 inhibitor class) were presented in Melbourne, Australia. Striking benefits were shown for individuals with Type 2 diabetes-related kidney disease including a 30% reduction in progression of kidney disease, 20% reduction in cardiovascular death/heart attack/stroke […]

READ MORE

Why you should write your politician about life-saving diabetes treatments

Living With Diabetes

BCDiabetes has been advocating for Pharmacare coverage of the life-saving SGLT2 inhibitor class of medication for more than 2 years, without success (see this video made with Diabetes Canada & previous blogs here and here). These newer treatments (SGLT2 inhibitors) are covered in every Canadian province except BC. In the 2019-Feb budget a new $43M […]

READ MORE

Statins for all?

Living With Diabetes,News & Media,Research

On February 1, 2019, the prestigious medical journal the Lancet published a meta-analysis examining potential benefits the statin and class of medication. The article confirmed and extended the powerful evidence for benefit for the use of statins in people with a previous history of heart disease, stroke and for those with diabetes.  It showed that […]

READ MORE

HCTZ and Risk of Skin Cancer

News & Media

Yesterday Health Canada issued a warning around HCTZ (hydrochlorothiazide), a commonly used diuretic blood pressure lowering medication: The warning was issued because of new evidence suggesting a 4-fold increased risk of non-melanoma skin cancer in individuals who have taken HCTZ for 3+ years. Non-melanoma skin cancer is made up of  basal-cell skin cancer (BCC) & […]

READ MORE

BC Diabetes Fundraising Event

Announcements,Events,News & Media

I began specialist diabetes practice in 1992 – with it began my lifetime mission to optimize care and improve outcomes for every British Columbian living with diabetes.  As my staff grew I realized that everything depended on teamwork – thus in 2005 was born BCDiabetes.   BCDiabetes, with its dedicated staff of 14, is now […]

READ MORE

Health Canada approves insulin pump with partial artificial pancreas capability

Announcements,Living With Diabetes,News & Media

2018-Oct-10 saw Health Canada approve the Medtronic 670G insulin pump, the first of its kind in Canada to support closed-loop functionality for basal insulin.  This innovation, the first step towards an artificial pancreas, is welcome news for every individual with diabetes who is an intensive insulin user (either a pumper or taking multiple daily shots). […]

READ MORE

Lead toxicity – a new risk factor for heart attack and stroke?

Announcements,Research

Lead is a naturally occurring element present in soil and rock – as such lead enters the water supply by a process of leaching. Lead is easily mined and smelted & because it is soft and easily shaped lead was widely used by the ancients to make implements for eating and for drinking and for […]

READ MORE

Insulin pumps for all intensive insulin users

Announcements,Living With Diabetes,News & Media,Technology

Kudos to the BC NDP government for extending insulin pump coverage to every British Columbian living with diabetes requiring intensive insulin therapy (effectively all those with Type 1 diabetes and those with Type 2 diabetes taking two different kinds of insulin).  On Tuesday the Minister of Health, Adrian Dix (who has Type 1 diabetes himself […]

READ MORE

Patient advocacy works! CRA reverses policy on Disability Tax Credit for Type 1 diabetes

Announcements,Living With Diabetes,News & Media

On Oct 12 BCDiabetes blogged on the CRA Disability Tax Credit as it applied to Type 1 diabetes and how the CRA had moved the goalposts: see Type 1 Diabetes sucks but dont ask the CRA for sympathy. Good news – the CRA has reversed its policy: so it is back to the old rules […]

READ MORE

Mission not impossible – weight loss reverses Type 2 diabetes

Announcements,News & Media,Research

A Scottish study published today in the prestigious medical journal the Lancet showed that weight loss averaging 10 kg achieved with a total diet replacement using a 853 kcal/day packaged powder formula for 3–5 months resulted in “remission” of Type 2 diabetes in almost 50% of participants at 12 months.  Patients considered in remission had […]

READ MORE
Translate »